Table 2.
Medical Characteristics | No. 1 | % 1 |
---|---|---|
Cancer Type | ||
Breast | 35 | 49 |
Colorectal | 9 | 13 |
Leukemia | 2 | 3 |
Lung | 5 | 7 |
Lymphoma | 8 | 11 |
Ovarian | 4 | 6 |
Pancreatic | 3 | 4 |
Prostate | 2 | 3 |
Other | 4 | 6 |
Date of Diagnosis | ||
≤2013 | 6 | 8 |
2014–2015 | 16 | 22 |
2016–2017 | 24 | 33 |
2018–2019 | 20 | 28 |
Not reported | 6 | 8 |
Lymph Node Involvement | ||
Yes | 44 | 61 |
No | 20 | 28 |
Unsure | 6 | 8 |
Disease Stage | ||
Localized | 45 | 63 |
Metastatic: | 24 | 33 |
Bone | 3 | 4 |
Liver | 6 | 8 |
Lung | 4 | 6 |
Lymph Node | 18 | 25 |
Cancer Recurrence | ||
Yes | 9 | 13 |
No | 57 | 79 |
Unsure | 6 | 8 |
Treatment Exposure | ||
Surgery | 63 | 88 |
Chemotherapy | 64 | 89 |
Radiotherapy | 43 | 60 |
Other | 17 | 24 |
Treatment Status | ||
Current treatment | 18 | 25 |
Post treatment | 49 | 68 |
Not reported | 5 | 7 |
Treatment Complications | ||
Yes | 42 | 58 |
No | 27 | 38 |
Not Reported | 3 | 4 |
Current Side Effects | ||
Anxiety | 13 | 18 |
Decreased range of motion | 19 | 26 |
Decreased strength | 27 | 38 |
Depression | 11 | 15 |
Fatigue | 35 | 49 |
Loss of appetite | 8 | 11 |
Lymphedema | 12 | 17 |
Nausea/vomiting | 7 | 10 |
Pain | 23 | 32 |
Other | 13 | 18 |
1 Participant totals and percentages may not add up because some respondents did not answer all questions.